Copper and anti-anhedonic effect of ketamine in treatment-resistant depression

被引：20
作者：
Slupski, Jakub [1 ]
Cubala, Wieslaw Jerzy [1 ]
Gorska, Natalia [1 ]
Slupska, Anita [1 ]
Galuszko-Wegielnik, Maria [1 ]
机构：
[1] Med Univ Gdansk, Fac Med, Dept Psychiat, Debinki St 7 Build 25, PL-80952 Gdansk, Poland
来源：
MEDICAL HYPOTHESES | 2020年 / 144卷
关键词：
Copper; Ketamine; Anhedonia; Treatment-resistant depression; ANTIDEPRESSANT TREATMENT; MAJOR DEPRESSION; DISORDER; ZINC; IDEATION; SUICIDE;
D O I：
10.1016/j.mehy.2020.110268
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Treatment-resistant depression (TRD) remains one of the major psychiatric challenges worldwide. Search for non-monoaminergic agents, possibly effective in treatment of TRD is of prime importance. One of those agents is ketamine - a dissociative, anesthetic drug exhibiting a fast antidepressant action in patients with TRD. Concurrently, anhedonia appears to be significant symptom domain with far-reaching impact on course of treatment. There is data demonstrating that abnormal copper levels might be associated with symptoms of depression. As there is common denominator in ketamine and copper role in neurotransmission this paper is to explore the associations of blood copper levels and psychometric measures in patients with TRD in course of major depressive disorder (MDD) and bipolar disorder (BP), focusing on anhedonia measured with Snaith-Hamilton Pleasure Scale (SHAPS) score.
引用
收藏
页数：6
相关论文
共 56 条
[1]   NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses [J].
Autry, Anita E. ;
Adachi, Megunai ;
Nosyreva, Elena ;
Na, Elisa S. ;
Los, Maarten F. ;
Cheng, Peng-fei ;
Kavalali, Ege T. ;
Monteggia, Lisa M. .
NATURE, 2011, 475 (7354) :91-U109
[2]   Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials [J].
Ballard, Elizabeth D. ;
Wills, Kathleen ;
Lally, Niall ;
Richards, Erica M. ;
Luckenbaugh, David A. ;
Walls, Tessa ;
Ameli, Rezvan ;
Niciu, Mark J. ;
Brutsche, Nancy E. ;
Park, Lawrence ;
Zarate, Carlos A., Jr. .
JOURNAL OF AFFECTIVE DISORDERS, 2017, 218 :195-200
[3]  
Barceloux DG, 1999, COPPER J TOXICOL, DOI [10.1081/CLT-100102421., DOI 10.1081/CLT-100102421]
[4]   Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory [J].
Bechtholt-Gompf, Anita J. ;
Walther, Hali V. ;
Adams, Martha A. ;
Carlezon, William A., Jr. ;
Ongur, Dost ;
Cohen, Bruce M. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (10) :2049-2059
[5]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[6]   Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review [J].
Cao, Bing ;
Zhu, Judy ;
Zuckerman, Hannah ;
Rosenblat, Joshua D. ;
Brietzke, Elisa ;
Pan, Zihang ;
Subramanieapillai, Mehala ;
Park, Caroline ;
Lee, Yena ;
McIntyre, Roger S. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 92 :109-117
[7]   Metabolic crossroads of iron and copper [J].
Collins, James F. ;
Prohaska, Joseph R. ;
Knutson, Mitchell D. .
NUTRITION REVIEWS, 2010, 68 (03) :133-147
[8]   Elevated serum copper levels in women with a history of post-partum depression [J].
Crayton, John W. ;
Walsh, William J. .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2007, 21 (01) :17-21
[9]   Lateral Diffusion of Gαs in the Plasma Membrane Is Decreased after Chronic but not Acute Antidepressant Treatment: Role of Lipid Raft and Non-Raft Membrane Microdomains [J].
Czysz, Andrew H. ;
Schappi, Jeffrey M. ;
Rasenick, Mark M. .
NEUROPSYCHOPHARMACOLOGY, 2015, 40 (03) :766-773
[10]   The promise of ketamine for treatment-resistant depression: current evidence and future directions [J].
DeWilde, Kaitlin E. ;
Levitch, Cara F. ;
Murrough, James W. ;
Mathew, Sanjay J. ;
Iosifescu, Dan V. .
AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY, 2015, 1345 :47-58
123456